Altered mRNA transport and local translation in i3Neurons with RNA-binding protein knockdown
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Rachael Dargan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Alzheimer's and Related Dementias, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, United States. Hauptthemen laut MEDLINE: RNA, Messenger, Protein Biosynthesis, RNA-Binding Proteins, DNA-Binding Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, HHS.
Abstract (Originalsprache)
Neurons rely on messenger RNA (mRNA) transport and local translation to facilitate rapid protein synthesis in processes far from the cell body. These processes allow precise spatial and temporal control of translation and are mediated by RNA-binding proteins (RBPs), including those associated with neurodegenerative diseases. Here, we use proteomics, transcriptomics, and microscopy to investigate the impact of RBP depletion on mRNA transport and local translation in induced pluripotent stem cell-derived neurons. We find thousands of transcripts enriched in neurites and that many of these transcripts are locally translated, possibly due to the shorter length of transcripts in neurites. Loss of frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS)-associated RBPs TDP-43 and hnRNPA1 induce distinct alterations in the neuritic proteome and transcriptome. TDP-43 knockdown (KD) leads to slightly increased neuritic mRNA and translation, while hnRNPA1 loss has more moderate effects on local mRNA profiles, possibly due to compensation by hnRNPA3. These results highlight the crucial role of FTD/ALS-associated RBPs in mRNA transport and local translation in neurons and the importance of these processes in neuron health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Alzheimer's and Related Dementias, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, United States.
- UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.
- DataTecnica, Washington, DC 20812 United States.
- National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, United States.
- Francis Crick Institute, London NW1 1AT, United Kingdom.
ORCID-Profile: Ziyi Li, Colleen Bereda, Ying Hao, Pietro Fratta, Veronica H Ryan
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- HHS
- NIH HHS
- NINDS NIH HHS
- Intramural NIH HHS
- Center for Alzheimer's and Related Dementias
- Center for Alzheimer’s and Related Dementias
Zitieren
APA
Dargan, R., Mikheenko, A., Johnson, N. L., Packer, B. E., Li, Z., Craig, E. J., Como, C. N., Sarbanes, S. L., Bereda, C., Hao, Y., Mehta, P. R., Keuss, M., Nalls, M. A., Qi, Y. A., Weller, C. A., Fratta, P., & Ryan, V. H. (2025). Altered mRNA transport and local translation in i3Neurons with RNA-binding protein knockdown. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf709
Vancouver
Dargan R, Mikheenko A, Johnson NL, Packer BE, Li Z, Craig EJ, et al. Altered mRNA transport and local translation in i3Neurons with RNA-binding protein knockdown. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf709
BibTeX
@article{Dargan2025,
author = {Dargan, Rachael and Mikheenko, Alla and Johnson, Nicholas L and Packer, Benjamin E and Li, Ziyi and Craig, Emma J and Como, Christina N and Sarbanes, Stephanie L and Bereda, Colleen and Hao, Ying and Mehta, Puja R and Keuss, Matthew and Nalls, Mike A and Qi, Yue A and Weller, Cory A and Fratta, Pietro and Ryan, Veronica H},
title = {Altered mRNA transport and local translation in i3Neurons with RNA-binding protein knockdown},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf709}
}
EUVIMED